Trichomegaly following treatment with gefitinib (ZD1839).
Pascual
J C
JC
Bañuls
J
J
Belinchon
I
I
Blanes
M
M
Massuti
B
B
D000970:Antineoplastic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology*; D004791:Enzyme Inhibitors / Q000009:adverse effects; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D005260:Female; D000077156:Gefitinib; D006201:Hair Diseases / Q000139:chemically induced*; D006801:Humans; D008875:Middle Aged; D011799:Quinazolines / Q000009:adverse effects*
D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D011799:Quinazolines; D066246:ErbB Receptors; D000077156:Gefitinib